These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8956101)

  • 1. Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria.
    Hammen VL; Yorkston KM
    J Commun Disord; 1996; 29(6):429-44; quiz 444-5. PubMed ID: 8956101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Acoustic Speech Temporal Characteristics for Mandarin Speakers With Parkinson's Disease During Syllable Repetition and Passage Reading.
    He D; Feenaughty L; Wan Q
    Am J Speech Lang Pathol; 2023 Sep; 32(5):2232-2244. PubMed ID: 37625136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Clear Speech on the Duration of Silent Intervals at Syntactic and Phonemic Boundaries in the Speech of Individuals With Parkinson Disease.
    Gravelin AC; Whitfield JA
    Am J Speech Lang Pathol; 2019 Jul; 28(2S):793-806. PubMed ID: 31306598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speech and pause characteristics associated with voluntary rate reduction in Parkinson's disease and Multiple Sclerosis.
    Tjaden K; Wilding G
    J Commun Disord; 2011; 44(6):655-65. PubMed ID: 21767851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech rate and rhythm in Parkinson's disease.
    Skodda S; Schlegel U
    Mov Disord; 2008 May; 23(7):985-992. PubMed ID: 18383114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of speaking task on intelligibility in Parkinson's disease.
    Tjaden K; Wilding G
    Clin Linguist Phon; 2011 Feb; 25(2):155-68. PubMed ID: 20887216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria.
    Hammen VL; Yorkston KM; Minifie FD
    J Speech Hear Res; 1994 Apr; 37(2):244-53. PubMed ID: 8028306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rate control on the intelligibility and naturalness of dysarthric speech.
    Yorkston KM; Hammen VL; Beukelman DR; Traynor CD
    J Speech Hear Disord; 1990 Aug; 55(3):550-60. PubMed ID: 2381196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SPEAK OUT! & LOUD Crowd on Functional Speech Measures in Parkinson's Disease.
    Sullivan L; Martin E; Allison KM
    Am J Speech Lang Pathol; 2024 Jul; 33(4):1930-1951. PubMed ID: 38838243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rate control on speech production and intelligibility in dysarthria.
    Van Nuffelen G; De Bodt M; Vanderwegen J; Van de Heyning P; Wuyts F
    Folia Phoniatr Logop; 2010; 62(3):110-9. PubMed ID: 20424466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clear speech on acoustic measures of dysprosody in Parkinson disease for different reading tasks.
    Coy AG; Whitfield JA
    Int J Speech Lang Pathol; 2023 Sep; ():1-14. PubMed ID: 37668056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the distribution of silent intervals in the connected speech of individuals with Parkinson disease.
    Whitfield JA; Gravelin AC
    J Commun Disord; 2019; 78():18-32. PubMed ID: 30612045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic Predictors of Ease of Understanding in Spanish Speakers With Dysarthria Associated With Parkinson's Disease.
    Moya-Galé G; Wisler AA; Walsh SJ; McAuliffe MJ; Levy ES
    J Speech Lang Hear Res; 2023 Aug; 66(8S):2999-3012. PubMed ID: 36508721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
    Boutsen F; Park E; Dvorak J; Cid C
    Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.